EMMA designs, implements, and remediates Quality Management Systems aligned with FDA, ISO, and global regulatory requirements. We tailor QMS frameworks to your organization’s size, product portfolio, and risk profile while ensuring scalability for growth. Our team supports documentation development, governance models, and operational integration to ensure quality is embedded into daily operations. We focus on building practical, inspection-ready systems that drive compliance without unnecessary complexity. Ongoing support ensures sustained effectiveness and regulatory confidence.

EMMA supports organizations through ISO certification and recertification processes, including ISO 13485, ISO 9001, and related standards. We perform gap assessments, develop remediation plans, and prepare documentation aligned with certification requirements. Our team leads internal readiness activities and supports interactions with notified bodies and auditors. We emphasize efficient preparation to reduce disruption while strengthening overall quality maturity. The result is a durable certification strategy that supports both compliance and business objectives.

We help organizations establish and manage robust supplier quality programs across global supply chains. EMMA supports supplier qualification, performance monitoring, and risk-based oversight models aligned with regulatory expectations. Our team assists with supplier agreements, quality metrics, and escalation processes to ensure accountability. We focus on proactive risk prevention rather than reactive issue management. This approach strengthens supply reliability while maintaining regulatory compliance.

EMMA conducts internal, supplier, and inspection-readiness audits using experienced auditors with regulatory and industry backgrounds. Our audits go beyond checklist compliance to identify systemic risks and improvement opportunities. We provide clear findings, practical remediation guidance, and leadership-ready reporting. For readiness audits, we simulate regulatory inspections to prepare teams for real-world interactions. This ensures confidence and control ahead of critical audits or inspections.

EMMA implements risk management frameworks aligned with ISO 14971 and global regulatory expectations. We support risk identification, analysis, mitigation, and documentation across product lifecycles and operations. Our team integrates risk management into design, manufacturing, and post-market activities. We emphasize traceability and defensible decision-making to support inspections and submissions. This structured approach reduces surprises and strengthens compliance posture.

We design and remediate Corrective and Preventive Action systems that meet regulatory expectations and drive sustainable improvement. EMMA supports root cause analysis, CAPA effectiveness checks, and governance processes. Our team ensures CAPAs are risk-based, timely, and fully integrated into quality systems. We focus on eliminating repeat issues rather than superficial fixes. This strengthens inspection outcomes and operational reliability.

EMMA supports the development and execution of compliant complaint handling processes across regulated markets. We ensure proper intake, investigation, trending, and escalation aligned with FDA and global requirements. Our team integrates complaint handling with vigilance, CAPA, and risk management systems. We focus on building efficient workflows that maintain compliance without slowing operations. This ensures timely issue resolution and regulatory confidence.

We help organizations assess and strengthen data integrity across quality and manufacturing systems. EMMA evaluates governance, controls, and behaviors that impact data reliability and traceability. Our team supports remediation aligned with FDA and global data integrity guidance. We focus on practical, sustainable controls rather than excessive documentation. This protects inspection outcomes and decision-making credibility.

EMMA provides validation support for computerized systems, processes, and equipment across regulated environments. We develop risk-based validation strategies aligned with FDA and global expectations. Our team supports CSV planning, execution, documentation, and remediation. We balance compliance rigor with operational efficiency to avoid over-validation. This ensures systems are fit-for-purpose, defensible, and inspection-ready.